PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice
| Autor: | Bosnjak, Masa, Jesenko, Tanja, Markelc, Bostjan, Janzic, Larisa, Cemazar, Maja, Sersa, Gregor |
|---|---|
| Zdroj: | In Bioelectrochemistry August 2021 140 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect